PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
03-Feb-2022 eTheRNA Announces Research Agreement with Merck to access mRNA technologies eTheRNA immunotherapies NV
03-Feb-2022 NICE ISSUES FINAL RECOMMENDATION FOR FORXIGA (dapagliflozin) IN THE TREATMENT OF ADULT PATIENTS WITH CHRONIC KIDNEY DISEASE AstraZeneca
03-Feb-2022 Zetta Genomics gains £2.5m seed funding to realise the power of genomic data in precision medicine Zetta Genomics
03-Feb-2022 ADVANCED CLINICAL NAMED 2022 BEST OF STAFFING® CLIENT AND TALENT DIAMOND AWARD WINNER Advanced Clinical
03-Feb-2022 European cancer coalition led by EORTC calls for ‘Treatment Optimization’ to become an EU-wide parameter in novel cancer therapies development to improve outcomes in cancer treatment. The European Organisation for Research and Treatment of Cancer (EORTC)
03-Feb-2022 DNA Script Joins Wellcome Leap R3 Program to Advance RNA Products and Therapies DNA Script
03-Feb-2022 UNICEF and Lilly Collaborate to Help Improve Health Outcomes for 10 Million Children and Adolescents Lilly
03-Feb-2022 Australians With One Of The Most Agressive Forms Of Blood Cancer Have New PBS Listed Treatment Option AstraZeneca
03-Feb-2022 iOmx Therapeutics Appoints Dr. Murray Yule as CMO to Lead Clinical Development iOmx Therapeutics AG
03-Feb-2022 Biophytis received approval from ANVISA (Brazil) to give access to Sarconeos (BIO101) to hospitalized COVID-19 patients through an Expanded Access Program Biophytis
03-Feb-2022 Parkinson’s UK and Domainex collaborate to develop therapies targeting neuroinflammation to slow the progression of Parkinson’s Sciad Newswire
03-Feb-2022 Kuros Biosciences’s MagnetOs Granules cleared by FDA for expanded spinal indications Kuros Biosciences AG
03-Feb-2022 Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS) Takeda Pharmaceutical Company Limited
02-Feb-2022 Reaction Biology Announces Integrated Drug Discovery Solutions: The Reaction Oncology Platform B3C newswire
02-Feb-2022 EISAI RECEIVES THE TOKYO GOVERNOR PRIZE FOR CORPORATE GOVERNANCE OF THE YEAR® 2021 EISAI
02-Feb-2022 Relief Therapeutics Expands Its Board of Directors with the Appointment of Michelle Lock RELIEF THERAPEUTICS Holding AG
01-Feb-2022 Listing and first trading day on the 'Sparks' segment of SIX Swiss Exchange expected for February 11, 2022 Xlife Sciences AG
01-Feb-2022 BRAIN Group significantly expands its food enzyme business with the acquisition of Breatec B.V. and Comix business BRAIN Biotech AG
01-Feb-2022 BRAIN Biotech AG: BRAIN Group expands its food enzyme business with the acquisition of a majority of Breatec B.V. and Comix BRAIN Biotech AG
01-Feb-2022 Coriolis Pharma Opens New ATMP Formulation Development Facilities B3C newswire